258 related articles for article (PubMed ID: 17697748)
1. Bisphosphonates in cancer therapy.
Stresing V; Daubiné F; Benzaid I; Mönkkönen H; Clézardin P
Cancer Lett; 2007 Nov; 257(1):16-35. PubMed ID: 17697748
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antitumor effects of bisphosphonates.
Clézardin P; Fournier P; Boissier S; Peyruchaud O
Curr Med Chem; 2003 Jan; 10(2):173-80. PubMed ID: 12570716
[TBL] [Abstract][Full Text] [Related]
3. The antitumor potential of bisphosphonates.
Clézardin P
Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
[TBL] [Abstract][Full Text] [Related]
4. [Antitumour effects of bisphosphonates in breast cancer].
van de Ven S; Kroep JR; Hamdy NA; Sleeboom HP; Nortier HW
Ned Tijdschr Geneeskd; 2010; 154():A1951. PubMed ID: 21083955
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates in preclinical bone oncology.
Clézardin P; Benzaïd I; Croucher PI
Bone; 2011 Jul; 49(1):66-70. PubMed ID: 21145441
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis.
Green JR; Clézardin P
Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S3-9. PubMed ID: 12562045
[TBL] [Abstract][Full Text] [Related]
7. The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
Santini D; Vespasiani Gentilucci U; Vincenzi B; Picardi A; Vasaturo F; La Cesa A; Onori N; Scarpa S; Tonini G
Ann Oncol; 2003 Oct; 14(10):1468-76. PubMed ID: 14504045
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
Clézardin P; Ebetino FH; Fournier PG
Cancer Res; 2005 Jun; 65(12):4971-4. PubMed ID: 15958534
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates: preclinical review.
Green JR
Oncologist; 2004; 9 Suppl 4():3-13. PubMed ID: 15459425
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of bisphosphonates on breast cancer cells.
Senaratne SG; Colston KW
Breast Cancer Res; 2002; 4(1):18-23. PubMed ID: 11879555
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor potential of bisphosphonates.
Green JR
Med Klin (Munich); 2000 Oct; 95 Suppl 2():23-8. PubMed ID: 11089384
[TBL] [Abstract][Full Text] [Related]
12. Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
Santini D; Schiavon G; Angeletti S; Vincenzi B; Gasparro S; Grilli C; La Cesa A; Virzí V; Leoni V; Budillon A; Addeo SR; Caraglia M; Dicuonzo G; Tonini G
Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):383-96. PubMed ID: 18221048
[TBL] [Abstract][Full Text] [Related]
13. Potential anticancer properties of bisphosphonates.
Neville-Webbe HL; Gnant M; Coleman RE
Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates in cancer therapy.
Green JR
Curr Opin Oncol; 2002 Nov; 14(6):609-15. PubMed ID: 12409650
[TBL] [Abstract][Full Text] [Related]
15. Potential anticancer properties of bisphosphonates: insights from preclinical studies.
Clezardin P
Anticancer Agents Med Chem; 2012 Feb; 12(2):102-13. PubMed ID: 21864232
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].
Clézardin P
Bull Cancer; 2010 Aug; 97(8):937-49. PubMed ID: 20595092
[TBL] [Abstract][Full Text] [Related]
17. New role for an established drug? Bisphosphonates as potential anticancer agents.
Koul HK; Koul S; Meacham RB
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):111-9. PubMed ID: 21876554
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumor cell invasion.
Woodward JK; Coleman RE; Holen I
Anticancer Drugs; 2005 Jan; 16(1):11-9. PubMed ID: 15613899
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.
Van Acker HH; Anguille S; Willemen Y; Smits EL; Van Tendeloo VF
Pharmacol Ther; 2016 Feb; 158():24-40. PubMed ID: 26617219
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen-containing bisphosphonates and cancer immunotherapy.
Clézardin P; Massaia M
Curr Pharm Des; 2010; 16(27):3007-2014. PubMed ID: 20722623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]